Table 1 Demographic characteristics of patients in the different treatment groups
Patient characteristics | 20 ml 0.5% ropivacaine (n = 9) | 30 ml 0.33% ropivacaine (n = 10) | 40 ml 0.25% ropivacaine (n = 10) |
|---|---|---|---|
Age (years) | 43.1 (5.5) | 44.1 (8.5) | 50.0 (7.1) |
Weight (kg) | 73.7 (16.5) | 64.6 (8.9) | 75 (13.1) |
Height (cm) | 160.3 (6.7) | 160.6 (5.2) | 166.5 (7.9) |
BMI (kg/m2) | 28.5 (5) | 24.7 (3.7) | 27.2 (4.8) |